Grown Rogue International (GRUSF) Return on Invested Capital (2020 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Return on Invested Capital of 472.85% in Q1 2026, down 510011.67% quarter-over-quarter from 0.09% in Q4 2025, and down 47285.0% on a YoY basis from N/an in Q1 2025.
Grown Rogue International (GRUSF) Return on Invested Capital (2020 - 2026) Analysis & Trends
Grown Rogue International's Return on Invested Capital history runs 5 years deep, the most recent figure standing at 472.85% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.00% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.01% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.00% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.00% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.00% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.00% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 0.00% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.00% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -472.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -472.85% |
| Dec 31, 2025 | -0.09% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 0.04% |
| Dec 31, 2023 | 0.05% |
| Oct 31, 2023 | 0.28% |
| Jul 31, 2023 | 0.05% |
| Jul 31, 2020 | -0.11% |
| Apr 30, 2020 | -0.06% |
| Jan 31, 2020 | -0.07% |